DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

A comparison of albumin-bolus therapy versus normal saline-bolus therapy for hypotension in neonates.

Author(s): Lynch SK, Mullett MD, Graeber JE, Polak MJ

Affiliation(s): Department of Pediatrics, Section of Neonatology, West Virginia University School of Medicine, Morgantown, WV 26506, USA. slynch@hsc.wvu.edu

Publication date & source: 2008-01, J Perinatol., 28(1):29-33. Epub 2007 Nov 8.

Publication type: Comparative Study; Randomized Controlled Trial

OBJECTIVE: We compared responses to bolus infusion of 5% albumin (ALB) or normal saline (NS) for hypotension in neonates. STUDY DESIGN: Hypotensive infants were given 10 ml kg(-1) of NS or ALB. A second bolus was given for persistent hypotension. Dopamine therapy was started for hypotension after the second bolus. The primary response was increase in arterial blood pressure toward normal range 1 h postinfusion. Secondary measures included duration of normotension, meeting criteria for second bolus, meeting criteria for vasopressor support and cost comparison. RESULT: Those receiving ALB (N=49 ALB and 52 NS) were more likely to achieve a normotensive state (ALB=57.1%, NS=32.1% P=0.01) 1 h following the initial bolus therapy. Subsequently, the NS group was also more likely to qualify for vasopressor infusion (ALB=24.5%, NS=44.2% P=0.02). Overall cost for either therapy was equivalent. CONCLUSION: In hypotensive neonates, ALB results in a greater likelihood of achieving normotension and decreased subsequent use of vasopressors when compared to NS.

Page last updated: 2008-03-26

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017